Cargando…
Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects
INTRODUCTION: Hypertension, hypercholesterolemia, and obesity increase the risk of dementia. Although their detection is commonly followed by an introduction of treatment, little is known about how medications frequently used to treat vascular risk affect amyloid deposition. METHODS: A cross-section...
Autores principales: | Glodzik, Lidia, Rusinek, Henry, Kamer, Angela, Pirraglia, Elizabeth, Tsui, Wai, Mosconi, Lisa, Li, Yi, McHugh, Pauline, Murray, John, Williams, Schantel, Osorio, Ricardo S., Randall, Catherine, Butler, Tracy, Deshpande, Anup, Vallabhajolusa, Shankar, de Leon, Mony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879519/ https://www.ncbi.nlm.nih.gov/pubmed/27239540 http://dx.doi.org/10.1016/j.dadm.2016.02.007 |
Ejemplares similares
-
Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome
por: Kamer, Angela R., et al.
Publicado: (2016) -
Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018) -
Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015) -
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
por: Pegueroles, Jordi, et al.
Publicado: (2020) -
Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)